Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

Findings of the study into choriocarcinoma ... It can also happen following a molar pregnancy (no embryo forms, and the placental tissue grows abnormally) and even after a full-term pregnancy.

The biggest risk factor for getting choriocarcinoma is having a hydatidiform mole (HM)—a rare mass that grows in the uterus at the start of pregnancy. This condition is also called a molar ...

Scientists have found a way to combat a rare, aggressive form of cancer affecting pregnant women and to better ensure the drug used for the disease reaches tumor cells without damaging healthy tissue.

arises from faulty placental cells and comprises several rare conditions including molar pregnancies and choriocarcinoma. Molar pregnancies can initially be experienced as a typical pregnancy but will ...

Recent work has conclusively shown that partial moles can transform into choriocarcinoma and placental-site trophoblastic tumor, therefore all patients with partial moles and complete moles ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well. Scientists led by ...